Status:

UNKNOWN

500 "Normal" Adult Subjects Who Have Experienced no Known Brain Injury Will Participate in Collecting Data That Will Assist With the Optimization of the Diagnostic Capabilities of the Harmony in Detecting Neurologic Abnormalities.

Lead Sponsor:

MindRhythm, Inc.

Conditions:

Cranial Waveform in Normal Patients as a Result of Cardiac Cycle

Healthy

Eligibility:

All Genders

18-100 years

Brief Summary

The REFRESH study is designed to collect data related to a signal in the brain that MindRhythm has named the Headpulse. The Headpulse occurs as a natural movement of the brain in conjunction with the ...

Detailed Description

This study will involve recordings using MindRhythm's Harmony 4000, a novel, non-invasive investigative medical device. The Harmony 4000 collects accelerometry data on the motion of the skull resultin...

Eligibility Criteria

Inclusion

  • Male and female adults from the age of 18 who have the ability to consent with no surrogates.
  • \-

Exclusion

  • Open wound to the head, pregnant women, not suitable for participation per the opinion of the PI.
  • \-

Key Trial Info

Start Date :

January 15 2023

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

January 15 2023

Estimated Enrollment :

500 Patients enrolled

Trial Details

Trial ID

NCT05203393

Start Date

January 15 2023

End Date

January 15 2023

Last Update

November 16 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

MindRhythm Incorporated

Cupertino, California, United States, 95014